Lawrence Annison
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Lawrence Annison has a total of 59 co-authors. Here are the top co-authors by number of shared publications:
- Samuel Antwi-Baffour
Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana
9 shared publications - Benjamin Tetteh Mensah
Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana
5 shared publications - Dorinda Naa Okailey Armah
Department of Medical Laboratory Sciences, School of Biomedical and Allied Health Sciences, College of Health Sciences, University of Ghana, Accra, Ghana
3 shared publications - Frank Twum Aboagye
Affiliation Biomedical and Public Health Research Unit, Water Research Institute, Council for Scientific and Industrial Research, Accra, Ghana
2 shared publications - Henry Kwadwo Hackman
Department of Medical Laboratory Technology, Faculty of Applied Sciences, Accra Technical University, Accra, Ghana
2 shared publications - Ransford Kyeremeh
Department of Medical Laboratory Sciences, School of Allied Health Sciences, College of Health Sciences, University of Ghana, P.O. Box KB 143, Korle-Bu, Accra, Ghana
2 shared publications
Latest Publications
- Open Access
- 11 August 2026
- Published by Springer Nature in BMC Research Notes
- Vol. 19 (1)
Impact of red blood cell transfusion on clinical and hematological outcomes in hospitalized patients
- 11 August 2026
- Published by Springer Nature in BMC Research Notes
- Vol. 19 (1)
Open AccessImpact of red blood cell transfusion on clinical and hematological outcomes in hospitalized patients
- Open Access
- 28 May 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (6) , e72176
Antibiotic Resistance Profile of Wound Infection Isolates: High Resistance to Cephalosporins and Penicillin Among Ghanaian Patients in a Cross‐Sectional Study
Background and Aim: Antibiotics remain among the most frequently prescribed medications in clinical practice. However, antimicrobial resistance (AMR) is an inevitable and irreversible consequence of bacterial adaptation to antimicrobial exposure. Despite its clinical importance, data on antibiotic resistance patterns of bacteria from wound infections in Ghana are limited. This study evaluated the prevalence and magnitude of antibiotic resistance among bacterial isolates from infected wounds in a Ghanaian population. Methods: This experimental cross‐sectional study enrolled 300 patients with suspected wound infections receiving care at MDS‐Lancet Laboratories. Wound swabs were collected, cultured on standard media, and incubated at 37°C for 18–24 h, with a second overnight reading. Bacterial identification was based on colony morphology, Gram staining, biochemical testing, and API 20 E/NE. Antimicrobial susceptibility was determined using the disc diffusion method. Data analysis was conducted using SPSS v26.0 and GraphPad v9.5. Results: The predominant isolates were Escherichia coli (23.2%), Pseudomonas aeruginosa (19.8%), Klebsiella spp. (19.2%), and Staphylococcus aureus (15.2%). Gram‐negative isolates were most susceptible to aminoglycosides (Amikacin, Gentamicin), carbapenems (Ertapenem, Imipenem, Meropenem), and Tigecycline, whilst showing high resistance to 2nd, 3rd and 4th generation cephalosporins (Cefuroxime, Ceftriaxone, and Cefepime, respectively) and Amoxicillin. Gram‐positive isolates, including S. aureus and coagulase‐negative staphylococci, were most susceptible to Gentamicin, Clindamycin, and Erythromycin, but resistant to 1st‐ and 2nd‐generation cephalosporins (Cefazolin and Cefoxitin respectively), penicillins (Augmentin and Cloxacillin), and Tetracycline. Extended‐spectrum β‐lactamase (ESBL) producers accounted for 30.3% of isolates, predominantly E. coli (50%) and Klebsiella spp. (43.9%). Methicillin‐resistant S. aureus (MRSA) and methicillin‐resistant coagulase‐negative staphylococci (MRCNS) were observed in 34.7% and 66.7% of isolates, respectively. Conclusion: Aminoglycosides and Linezolid are most effective against Gram‐positive and Gram‐negative bacteria causing wound infections. However, both Gram‐positive and Gram‐negative bacteria are resistant to 2nd generation cephalosporins and penicillin. High resistance to cephalosporins and penicillin calls for the necessity of culture‐guided therapy for effective wound infection management.
- 28 May 2026
- Published by Wiley in Health Science Reports
- Vol. 9 (6) , e72176
Open AccessAntibiotic Resistance Profile of Wound Infection Isolates: High Resistance to Cephalosporins and Penicillin Among Ghanaian Patients in a Cross‐Sectional Study
Background and Aim: Antibiotics remain among the most frequently prescribed medications in clinical practice. However, antimicrobial resistance (AMR) is an inevitable and irreversible consequence of bacterial adaptation to antimicrobial exposure. Despite its clinical importance, data on antibiotic resistance patterns of bacteria from wound infections in Ghana are limited. This study evaluated the prevalence and magnitude of antibiotic resistance among bacterial isolates from infected wounds in a Ghanaian population. Methods: This experimental cross‐sectional study enrolled 300 patients with suspected wound infections receiving care at MDS‐Lancet Laboratories. Wound swabs were collected, cultured on standard media, and incubated at 37°C for 18–24 h, with a second overnight reading. Bacterial identification was based on colony morphology, Gram staining, biochemical testing, and API 20 E/NE. Antimicrobial susceptibility was determined using the disc diffusion method. Data analysis was conducted using SPSS v26.0 and GraphPad v9.5. Results: The predominant isolates were Escherichia coli (23.2%), Pseudomonas aeruginosa (19.8%), Klebsiella spp. (19.2%), and Staphylococcus aureus (15.2%). Gram‐negative isolates were most susceptible to aminoglycosides (Amikacin, Gentamicin), carbapenems (Ertapenem, Imipenem, Meropenem), and Tigecycline, whilst showing high resistance to 2nd, 3rd and 4th generation cephalosporins (Cefuroxime, Ceftriaxone, and Cefepime, respectively) and Amoxicillin. Gram‐positive isolates, including S. aureus and coagulase‐negative staphylococci, were most susceptible to Gentamicin, Clindamycin, and Erythromycin, but resistant to 1st‐ and 2nd‐generation cephalosporins (Cefazolin and Cefoxitin respectively), penicillins (Augmentin and Cloxacillin), and Tetracycline. Extended‐spectrum β‐lactamase (ESBL) producers accounted for 30.3% of isolates, predominantly E. coli (50%) and Klebsiella spp. (43.9%). Methicillin‐resistant S. aureus (MRSA) and methicillin‐resistant coagulase‐negative staphylococci (MRCNS) were observed in 34.7% and 66.7% of isolates, respectively. Conclusion: Aminoglycosides and Linezolid are most effective against Gram‐positive and Gram‐negative bacteria causing wound infections. However, both Gram‐positive and Gram‐negative bacteria are resistant to 2nd generation cephalosporins and penicillin. High resistance to cephalosporins and penicillin calls for the necessity of culture‐guided therapy for effective wound infection management.
- 3 July 2025
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (4) , 104201
Evaluation of iron levels and hematological indices among blood donors at the Southern Zonal Blood Center, Accra, Ghana
- 3 July 2025
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (4) , 104201
Evaluation of iron levels and hematological indices among blood donors at the Southern Zonal Blood Center, Accra, Ghana
- 18 March 2025
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 49 (3) , 548-564
Overview of the host immune response to P. falciparum malaria
The host immune response to malaria is a complex interplay between the parasite, Plasmodium, and the human immune system. Upon infection, various components of the immune system, including innate and adaptive responses, are mobilized to combat the parasite. Innate immunity provides the initial defense, with cells such as macrophages, dendritic cells, and natural killer cells recognizing and responding to the parasite. Additionally, inflammatory cytokines are released to coordinate the immune response. The adaptive immune response, primarily involving T and B lymphocytes, plays a crucial role in controlling and eliminating the parasite. T cells recognize and destroy infected cells, while B cells produce antibodies that target specific antigens on the parasite's surface. These antibodies can neutralize the parasite, block its invasion of host cells, and facilitate its clearance by phagocytes. However, the development of protective immunity against malaria is complex and influenced by various factors, including parasite diversity, host genetics, and prior exposure to the parasite. While some individuals develop partial immunity over time, others remain susceptible to severe disease. Understanding the intricacies of the host immune response to malaria is essential for the development of effective vaccines and therapies to combat this global health burden.
- 18 March 2025
- Published by Springer Nature in Journal of Parasitic Diseases
- Vol. 49 (3) , 548-564
Overview of the host immune response to P. falciparum malaria
The host immune response to malaria is a complex interplay between the parasite, Plasmodium, and the human immune system. Upon infection, various components of the immune system, including innate and adaptive responses, are mobilized to combat the parasite. Innate immunity provides the initial defense, with cells such as macrophages, dendritic cells, and natural killer cells recognizing and responding to the parasite. Additionally, inflammatory cytokines are released to coordinate the immune response. The adaptive immune response, primarily involving T and B lymphocytes, plays a crucial role in controlling and eliminating the parasite. T cells recognize and destroy infected cells, while B cells produce antibodies that target specific antigens on the parasite's surface. These antibodies can neutralize the parasite, block its invasion of host cells, and facilitate its clearance by phagocytes. However, the development of protective immunity against malaria is complex and influenced by various factors, including parasite diversity, host genetics, and prior exposure to the parasite. While some individuals develop partial immunity over time, others remain susceptible to severe disease. Understanding the intricacies of the host immune response to malaria is essential for the development of effective vaccines and therapies to combat this global health burden.
- Open Access
- 4 June 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (6) , e0007324
Comparative evaluation of RT-PCR and antigen-based rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2 detection: performance, variant specificity, and clinical implications
The COVID-19 pandemic has highlighted the critical need for accurate and efficient diagnostic tools for detecting severe acute respiratory coronavirus 2 (SARS-CoV-2) infections. This study presents a comparison of two diagnostic tests: RT-PCR and antigen detection rapid diagnostic tests (Ag-RDTs). This study focused on their performance, variant specificity, and their clinical implications. A simultaneous testing of 268 samples was carried out for SARS-CoV-2 using RT-PCR and Ag-RDTs [flourescence immunoassay (FIA) and lateral flow immunoassay (LFIA)]. Viral load was quantified, and variant identification was performed using a PCR-based assay. The prevalence was found to be 30.2% using reverse transcription PCR (RT-PCR), 26.5% using FIA, and 25% using LFIA. When comparing the FIA and LFIA, the overall diagnostic performance was found to be 80.25% vs 76.54%, 96.79% vs 97.33%, 91.55% vs 90.51%, and 91.88% vs 92.56% for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), respectively. Both Ag-RDTs showed a strong agreement with RT-PCR (κ = 0.78–0.80). The overall accuracies of the FIA and LFIA were 92.41% and 92.13%, respectively. The FIA showed higher sensitivity (73.68%) and PPV (92.08%) than the LFIA (65.79% and 90.56%, respectively) in asymptomatic patients. At low Ct values ( 30. The diagnostic sensitivity of FIA compared to LFIA for detecting the Alpha variant was 78.85% vs. 69.23% and 72.22% vs. 83.33% for the Delta variant. Both Ag-RDTs had 100% sensitivity for detecting Omicron. Both Ag-RDTs performed well in patients with high viral loads and Omicron variant infections compared to those infected with Alpha and Delta variants. This study confirms the comparable performance of RT-PCR and Ag-RDTs, specifically FIA and LFIA, for SARS-CoV-2 detection. The FIA showed higher sensitivity and PPV in asymptomatic cases, while both Ag-RDTs exhibited strong agreement with RT-PCR results. Notably, Ag-RDTs, particularly FIA, proved effective in detecting the Omicron variant and cases with high viral loads, highlighting their potential clinical utility in managing the COVID-19 pandemic. IMPORTANCE: This study is of utmost importance in providing effective responses to manage the COVID-19 pandemic. It rigorously compares the diagnostic accuracy, variant specificity, and practical considerations of reverse transcription PCR (RT-PCR) and antigen detection rapid diagnostic tests (Ag-RDTs) for severe acute respiratory coronavirus 2 (SARS-CoV-2), answering critical questions. The results of this study will help healthcare professionals choose the appropriate testing methods, allocate resources effectively, and enhance public health strategies. Given the evolution of the virus, understanding the performance of these diagnostic tools is crucial to adapting to emerging variants. Additionally, the study provides insights into logistical challenges and accessibility issues, which will contribute to refining testing workflows, particularly in resource-limited settings. Ultimately, the study’s impact extends to global healthcare, providing valuable information for policymakers, clinicians, and public health officials as they work together for mitigating the impact of the pandemic.
- 4 June 2024
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 12 (6) , e0007324
Open AccessComparative evaluation of RT-PCR and antigen-based rapid diagnostic tests (Ag-RDTs) for SARS-CoV-2 detection: performance, variant specificity, and clinical implications
The COVID-19 pandemic has highlighted the critical need for accurate and efficient diagnostic tools for detecting severe acute respiratory coronavirus 2 (SARS-CoV-2) infections. This study presents a comparison of two diagnostic tests: RT-PCR and antigen detection rapid diagnostic tests (Ag-RDTs). This study focused on their performance, variant specificity, and their clinical implications. A simultaneous testing of 268 samples was carried out for SARS-CoV-2 using RT-PCR and Ag-RDTs [flourescence immunoassay (FIA) and lateral flow immunoassay (LFIA)]. Viral load was quantified, and variant identification was performed using a PCR-based assay. The prevalence was found to be 30.2% using reverse transcription PCR (RT-PCR), 26.5% using FIA, and 25% using LFIA. When comparing the FIA and LFIA, the overall diagnostic performance was found to be 80.25% vs 76.54%, 96.79% vs 97.33%, 91.55% vs 90.51%, and 91.88% vs 92.56% for sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV), respectively. Both Ag-RDTs showed a strong agreement with RT-PCR (κ = 0.78–0.80). The overall accuracies of the FIA and LFIA were 92.41% and 92.13%, respectively. The FIA showed higher sensitivity (73.68%) and PPV (92.08%) than the LFIA (65.79% and 90.56%, respectively) in asymptomatic patients. At low Ct values ( 30. The diagnostic sensitivity of FIA compared to LFIA for detecting the Alpha variant was 78.85% vs. 69.23% and 72.22% vs. 83.33% for the Delta variant. Both Ag-RDTs had 100% sensitivity for detecting Omicron. Both Ag-RDTs performed well in patients with high viral loads and Omicron variant infections compared to those infected with Alpha and Delta variants. This study confirms the comparable performance of RT-PCR and Ag-RDTs, specifically FIA and LFIA, for SARS-CoV-2 detection. The FIA showed higher sensitivity and PPV in asymptomatic cases, while both Ag-RDTs exhibited strong agreement with RT-PCR results. Notably, Ag-RDTs, particularly FIA, proved effective in detecting the Omicron variant and cases with high viral loads, highlighting their potential clinical utility in managing the COVID-19 pandemic. IMPORTANCE: This study is of utmost importance in providing effective responses to manage the COVID-19 pandemic. It rigorously compares the diagnostic accuracy, variant specificity, and practical considerations of reverse transcription PCR (RT-PCR) and antigen detection rapid diagnostic tests (Ag-RDTs) for severe acute respiratory coronavirus 2 (SARS-CoV-2), answering critical questions. The results of this study will help healthcare professionals choose the appropriate testing methods, allocate resources effectively, and enhance public health strategies. Given the evolution of the virus, understanding the performance of these diagnostic tools is crucial to adapting to emerging variants. Additionally, the study provides insights into logistical challenges and accessibility issues, which will contribute to refining testing workflows, particularly in resource-limited settings. Ultimately, the study’s impact extends to global healthcare, providing valuable information for policymakers, clinicians, and public health officials as they work together for mitigating the impact of the pandemic.
- Open Access
- 29 March 2024
- Published by Wiley in Advances in Virology
- Vol. 2024, 1-12
Molecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown
Introduction. Currently, sequencing has been the only tool for the identification of circulating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants. However, it is known to be an expensive and laborious approach involving high technical expertise. Considering the reduced adherence to preventive measures postlockdown in Accra, this study presents an alternative method that leverages polymerase chain reaction (PCR) to identify circulating SARS-CoV-2 variants in the Accra Metropolis postlockdown. Methods. This prospective cross-sectional study was conducted between July and December 2022. Nasopharyngeal samples were collected from 268 consenting participants. Samples were subjected to nucleic acid extraction and followed by real-time polymerase chain reaction for the detection and quantification of SARS-CoV-2 RNA. SARS-CoV-2 positive samples were subsequently subjected to variant identification using rapid PCR. Findings. The prevalence of SARS-CoV-2 within the Accra Metropolis was 30.2. The majority of the SARS-CoV-2 infection was diagnosed in females, participants aged 4150years, and symptomatic participants. Participants aged 10years and females recorded the highest viral load while participants aged 4150years recorded the highest number of infections. The SARS-CoV-2 variants detected were Alpha (64.2), Delta (22.2), and Omicron (13.6). Predictors of SARS-CoV-2 infection identified were chills, cough, headache, body weakness, sore throat, and dyspnoea in order of decreasing association with SARS-CoV-2 infection. There was a strong association between symptom status, gender, age, and SARS-CoV-2 infection. Conclusion. There was a high prevalence of SARS-CoV-2 within the Accra Metropolis postlockdown within the sampling period. The Alpha variant of SARS-CoV-2 is the predominant circulating variant, and persons presenting with symptoms are most likely to be diagnosed with COVID-19. Children aged 10years serve as a reservoir for infection transmission.
- 29 March 2024
- Published by Wiley in Advances in Virology
- Vol. 2024, 1-12
Open AccessMolecular Epidemiology of SARS-CoV-2 within Accra Metropolis Postlockdown
Introduction. Currently, sequencing has been the only tool for the identification of circulating severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) variants. However, it is known to be an expensive and laborious approach involving high technical expertise. Considering the reduced adherence to preventive measures postlockdown in Accra, this study presents an alternative method that leverages polymerase chain reaction (PCR) to identify circulating SARS-CoV-2 variants in the Accra Metropolis postlockdown. Methods. This prospective cross-sectional study was conducted between July and December 2022. Nasopharyngeal samples were collected from 268 consenting participants. Samples were subjected to nucleic acid extraction and followed by real-time polymerase chain reaction for the detection and quantification of SARS-CoV-2 RNA. SARS-CoV-2 positive samples were subsequently subjected to variant identification using rapid PCR. Findings. The prevalence of SARS-CoV-2 within the Accra Metropolis was 30.2. The majority of the SARS-CoV-2 infection was diagnosed in females, participants aged 4150years, and symptomatic participants. Participants aged 10years and females recorded the highest viral load while participants aged 4150years recorded the highest number of infections. The SARS-CoV-2 variants detected were Alpha (64.2), Delta (22.2), and Omicron (13.6). Predictors of SARS-CoV-2 infection identified were chills, cough, headache, body weakness, sore throat, and dyspnoea in order of decreasing association with SARS-CoV-2 infection. There was a strong association between symptom status, gender, age, and SARS-CoV-2 infection. Conclusion. There was a high prevalence of SARS-CoV-2 within the Accra Metropolis postlockdown within the sampling period. The Alpha variant of SARS-CoV-2 is the predominant circulating variant, and persons presenting with symptoms are most likely to be diagnosed with COVID-19. Children aged 10years serve as a reservoir for infection transmission.
- Open Access
- 5 October 2023
- Published by Springer Nature in BMC Research Notes
- Vol. 16 (1) , 1-6
Comparative analysis of glycated haemoglobin, fasting blood glucose and haematological parameters in Type-2 diabetes patients
Objective: Diabetes remains a major health problem, and Glycated hemoglobin (HBA1c) and fasting blood glucose (FBG) levels play important roles in its management. Also, chronic hyperglycemia coupled with high HBA1c levels impact inflammation and may alter haematological parameters in diabetes. Hence, the need to assess and correlate HBA1c and FBG levels with selected haematological parameters in patients with type-2 diabetes mellitus as the main objective of this study. The study was cross-sectional involving 384 participants. Five milliliters of blood was collected from each participant and analyzed for HBA1c, FBG levels and full blood count which were correlated statistically. Results: From the data obtained and analyzed, there were statistically significant correlations between HBA1c and neutrophil count (p < 0.013), plateletcrit (p < 0.036), mean platelet volume (p < 0.019) and platelet distribution width (p < 0.002). There were also significant differences in FBG (p < 0.014), neutrophil count (p < 0.029), red cell distribution width (p < 0.046), mean platelet volume (p < 0.032) and platelet distribution width (p < 0.013) between diabetes patients with HBA1c less than 7.0% and HBA1c more than or equal to 7.0%. The outcome of the study indicates significant correlation of HBA1c with selected haematological parameters. This could make routine haematological parameters a cost-effective means of predicting poor glucose control in diabetes mellitus patients.
- 5 October 2023
- Published by Springer Nature in BMC Research Notes
- Vol. 16 (1) , 1-6
Open AccessComparative analysis of glycated haemoglobin, fasting blood glucose and haematological parameters in Type-2 diabetes patients
Objective: Diabetes remains a major health problem, and Glycated hemoglobin (HBA1c) and fasting blood glucose (FBG) levels play important roles in its management. Also, chronic hyperglycemia coupled with high HBA1c levels impact inflammation and may alter haematological parameters in diabetes. Hence, the need to assess and correlate HBA1c and FBG levels with selected haematological parameters in patients with type-2 diabetes mellitus as the main objective of this study. The study was cross-sectional involving 384 participants. Five milliliters of blood was collected from each participant and analyzed for HBA1c, FBG levels and full blood count which were correlated statistically. Results: From the data obtained and analyzed, there were statistically significant correlations between HBA1c and neutrophil count (p < 0.013), plateletcrit (p < 0.036), mean platelet volume (p < 0.019) and platelet distribution width (p < 0.002). There were also significant differences in FBG (p < 0.014), neutrophil count (p < 0.029), red cell distribution width (p < 0.046), mean platelet volume (p < 0.032) and platelet distribution width (p < 0.013) between diabetes patients with HBA1c less than 7.0% and HBA1c more than or equal to 7.0%. The outcome of the study indicates significant correlation of HBA1c with selected haematological parameters. This could make routine haematological parameters a cost-effective means of predicting poor glucose control in diabetes mellitus patients.
- Open Access
- 25 September 2023
- Published by Springer Nature in Malaria Journal
- Vol. 22 (1) , 1-8
Haematological parameters and their correlation with the degree of malaria parasitaemia among outpatients attending a polyclinic
Background: Malaria is a parasitic disease caused by various species of the blood parasite Plasmodium; of all the parasitic diseases, malaria has the highest prevalence and mortality with an estimated 247 million cases and 619,000 deaths recorded worldwide as of 2021. Malaria causes febrile illness with several changes in blood cell parameters. Some of these changes include leucopenia, thrombocytopenia, and anaemia. If these changes could be correlated with the degree of parasitaemia, it can serve as a guide to physicians when treating malaria. This study was therefore aimed at correlating haematological parameters with levels of parasitaemia during malaria infection. Methods: The study was a cross-sectional study involving 89 malaria positive patients. About 5 ml of blood was collected from each participant who gave his or her informed consent to partake in the study. A full blood count was performed on their samples to determine their haematological parameters using a haematology auto-analyzer. A parasite count was also performed via microscopy to determine the degree of parasitaemia. The data obtained from the study was entered into a database and statistically analysed using Statistical Package for Social Sciences (SPSS) version 23 and Microsoft Excel 2016. Results: The study comprised of 89 participants out of which 35 were males and 54 were females with the mean age of 26.15 years. Secondary education participants were the highest with quaternary education the lowest. The highest parasite count recorded was 398,174 parasites/µl of blood, lowest count was 101 with the average being 32,942.32584. There was also a significant positive Pearson’s correlation between total WBC and parasitaemia and with the WBC differentials, neutrophils, lymphocytes and monocytes had positive correlations while eosinophils and basophils had negative correlations. Furthermore, platelets, total RBC’s, haemoglobin, MCH, MCHC and Hct all showed negative correlations. Linear regression also showed a linear relationship between parasite density and the various haematological parameters. Conclusion: The linear relationship (correlation) between WBC and MCH were the only significant ones at 95% and 99% confidence interval, respectively based on a two-tail t-test. Also, based on the regression analysis, the changes caused by WBC and PLT were the only significant changes at 95% confidence level in a two-tailed t-test.
- 25 September 2023
- Published by Springer Nature in Malaria Journal
- Vol. 22 (1) , 1-8
Open AccessHaematological parameters and their correlation with the degree of malaria parasitaemia among outpatients attending a polyclinic
Background: Malaria is a parasitic disease caused by various species of the blood parasite Plasmodium; of all the parasitic diseases, malaria has the highest prevalence and mortality with an estimated 247 million cases and 619,000 deaths recorded worldwide as of 2021. Malaria causes febrile illness with several changes in blood cell parameters. Some of these changes include leucopenia, thrombocytopenia, and anaemia. If these changes could be correlated with the degree of parasitaemia, it can serve as a guide to physicians when treating malaria. This study was therefore aimed at correlating haematological parameters with levels of parasitaemia during malaria infection. Methods: The study was a cross-sectional study involving 89 malaria positive patients. About 5 ml of blood was collected from each participant who gave his or her informed consent to partake in the study. A full blood count was performed on their samples to determine their haematological parameters using a haematology auto-analyzer. A parasite count was also performed via microscopy to determine the degree of parasitaemia. The data obtained from the study was entered into a database and statistically analysed using Statistical Package for Social Sciences (SPSS) version 23 and Microsoft Excel 2016. Results: The study comprised of 89 participants out of which 35 were males and 54 were females with the mean age of 26.15 years. Secondary education participants were the highest with quaternary education the lowest. The highest parasite count recorded was 398,174 parasites/µl of blood, lowest count was 101 with the average being 32,942.32584. There was also a significant positive Pearson’s correlation between total WBC and parasitaemia and with the WBC differentials, neutrophils, lymphocytes and monocytes had positive correlations while eosinophils and basophils had negative correlations. Furthermore, platelets, total RBC’s, haemoglobin, MCH, MCHC and Hct all showed negative correlations. Linear regression also showed a linear relationship between parasite density and the various haematological parameters. Conclusion: The linear relationship (correlation) between WBC and MCH were the only significant ones at 95% and 99% confidence interval, respectively based on a two-tail t-test. Also, based on the regression analysis, the changes caused by WBC and PLT were the only significant changes at 95% confidence level in a two-tailed t-test.
- Open Access
- 23 November 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (11) , e0278037
Seroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy
Chronic hepatitis negatively affects persons living with HIV. While varying in their transmission efficiency, HIV, HBV, and HCV have shared routes of transmission. Available data suggest widely variable rates of HBV and HCV infections in HIV-infected populations across sub-Saharan Africa. With prolonged survival rates due to increased accessibility to antiretroviral drugs, HBV and HCV have the potential to complicate the prognosis of HIV co-infected patients by contributing significantly to continued morbidity and mortality. The study sought to determine the seroprevalence of HIV/HBV and HIV/HCV co-infections among HIV patients on antiretroviral therapy and to evaluate the effect of HIV/HBV and HIV/HCV co-infections on the immunologic and virologic responses of patients. A cross-sectional study in which samples were taken from 500 people living with HIV and attending ART clinic at the Fevers unit of the Korle Bu Teaching Hospital and tested for Hepatitis B Surface Antigen (HBsAg) and Hepatitis C virus antibody (HCV). CD4 cell counts and HIV-1 RNA levels were estimated as well. Data generated were analysed using IBM SPSS version 22. The seroprevalence of HIV/HBV and HIV/HCV co-infections among people living with HIV was 8.4% and 0.2% respectively. HIV/HBV coinfection included 15/42 (35.7%) males and 27/42 (64.3%) females out of which the majority (97.6%) were in the 21–60 years old bracket. HIV/HBV and HIV/HCV co-infections have varied effects on the immunological and virological response of HIV patients on ART. The mean CD cell count was 361.0 ± 284.0 in HIV/HBV co-infected patients and 473.8 ± 326.7 in HIV mono-infected patients. The mean HIV-1 RNA level was not significantly different (X2 [df] = .057 [1]; P = .811) among HIV/HBV co-infected patients (Log102.9±2.0 copies/mL), compared to that of HIV mono-infected patients (Log102.8±2.1 copies/mL) although HIV mono-infected patients had lower viral load levels. One-third (14/42) of HIV/HBV co-infected patients had virologic failure and the only HIV/HCV co-infected patient showed viral suppression. 336/500 (67.2%) patients had HIV-1 viral suppression (females [66.1%]; males [33.9%]) while 164/500 (32.8%) had virologic failure (females [67.7%]; males [32.3%]). The mean CD4 count of patients with viral suppression and patients with virologic failure was 541.2 cells/μL (95% CI 508.5–573.8) and 309.9 cell/μL (95% CI 261.9–357.9) respectively.The study concludes that, HIV/HBV and HIV/HCV coinfections do not significantly affect the immunologic and virologic responses of patients who have initiated highly active antiretroviral therapy, and treatment outcomes were better in females than in males. There was no HBV/HCV co-infection among patients.
- 23 November 2022
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 17 (11) , e0278037
Open AccessSeroprevalence and effect of HBV and HCV co-infections on the immuno-virologic responses of adult HIV-infected persons on anti-retroviral therapy
Chronic hepatitis negatively affects persons living with HIV. While varying in their transmission efficiency, HIV, HBV, and HCV have shared routes of transmission. Available data suggest widely variable rates of HBV and HCV infections in HIV-infected populations across sub-Saharan Africa. With prolonged survival rates due to increased accessibility to antiretroviral drugs, HBV and HCV have the potential to complicate the prognosis of HIV co-infected patients by contributing significantly to continued morbidity and mortality. The study sought to determine the seroprevalence of HIV/HBV and HIV/HCV co-infections among HIV patients on antiretroviral therapy and to evaluate the effect of HIV/HBV and HIV/HCV co-infections on the immunologic and virologic responses of patients. A cross-sectional study in which samples were taken from 500 people living with HIV and attending ART clinic at the Fevers unit of the Korle Bu Teaching Hospital and tested for Hepatitis B Surface Antigen (HBsAg) and Hepatitis C virus antibody (HCV). CD4 cell counts and HIV-1 RNA levels were estimated as well. Data generated were analysed using IBM SPSS version 22. The seroprevalence of HIV/HBV and HIV/HCV co-infections among people living with HIV was 8.4% and 0.2% respectively. HIV/HBV coinfection included 15/42 (35.7%) males and 27/42 (64.3%) females out of which the majority (97.6%) were in the 21–60 years old bracket. HIV/HBV and HIV/HCV co-infections have varied effects on the immunological and virological response of HIV patients on ART. The mean CD cell count was 361.0 ± 284.0 in HIV/HBV co-infected patients and 473.8 ± 326.7 in HIV mono-infected patients. The mean HIV-1 RNA level was not significantly different (X2 [df] = .057 [1]; P = .811) among HIV/HBV co-infected patients (Log102.9±2.0 copies/mL), compared to that of HIV mono-infected patients (Log102.8±2.1 copies/mL) although HIV mono-infected patients had lower viral load levels. One-third (14/42) of HIV/HBV co-infected patients had virologic failure and the only HIV/HCV co-infected patient showed viral suppression. 336/500 (67.2%) patients had HIV-1 viral suppression (females [66.1%]; males [33.9%]) while 164/500 (32.8%) had virologic failure (females [67.7%]; males [32.3%]). The mean CD4 count of patients with viral suppression and patients with virologic failure was 541.2 cells/μL (95% CI 508.5–573.8) and 309.9 cell/μL (95% CI 261.9–357.9) respectively.The study concludes that, HIV/HBV and HIV/HCV coinfections do not significantly affect the immunologic and virologic responses of patients who have initiated highly active antiretroviral therapy, and treatment outcomes were better in females than in males. There was no HBV/HCV co-infection among patients.
- Open Access
Severity of Anaemia Has Corresponding Effects on Coagulation Parameters of Sickle Cell Disease Patients
Sickle cell disease (SCD) is an inherited condition characterized by chronic haemolytic anaemia. SCD is associated with moderate to severe anaemia, hypercoagulable state and inconsistent platelet count and function. However, studies have yielded conflicting results with regards to the effect of anaemia on coagulation in SCD. The purpose of this study was to determine the effect of anaemia severity on selected coagulation parameters of SCD patients. Four millilitres of venous blood samples were taken from the participants (SCD and non-SCD patients) and used for analysis of full blood count and coagulation parameters. Data was analysed using SPSS version-16. From the results, it was seen that individuals with SCD had a prolonged mean PT, APTT and high platelet count compared to the controls. There was also significant difference in the mean PT (p = 0.039), APTT (p = 0.041) and platelet count (p = 0.010) in HbSS participants with severe anaemia. Mean APTT also showed significant difference (p = 0.044) with severe anaemia in HbSC participants. It can be concluded that SCD patients have prolonged PT, APTT and increased platelet count which might predispose them to bleeding episodes and thrombocytosis. Significant difference was also seen between severity of anaemia and mean PT, APTT and platelet count in HbSS individuals.
Open AccessSeverity of Anaemia Has Corresponding Effects on Coagulation Parameters of Sickle Cell Disease Patients
Sickle cell disease (SCD) is an inherited condition characterized by chronic haemolytic anaemia. SCD is associated with moderate to severe anaemia, hypercoagulable state and inconsistent platelet count and function. However, studies have yielded conflicting results with regards to the effect of anaemia on coagulation in SCD. The purpose of this study was to determine the effect of anaemia severity on selected coagulation parameters of SCD patients. Four millilitres of venous blood samples were taken from the participants (SCD and non-SCD patients) and used for analysis of full blood count and coagulation parameters. Data was analysed using SPSS version-16. From the results, it was seen that individuals with SCD had a prolonged mean PT, APTT and high platelet count compared to the controls. There was also significant difference in the mean PT (p = 0.039), APTT (p = 0.041) and platelet count (p = 0.010) in HbSS participants with severe anaemia. Mean APTT also showed significant difference (p = 0.044) with severe anaemia in HbSC participants. It can be concluded that SCD patients have prolonged PT, APTT and increased platelet count which might predispose them to bleeding episodes and thrombocytosis. Significant difference was also seen between severity of anaemia and mean PT, APTT and platelet count in HbSS individuals.